tradingkey.logo

Cencora Inc

COR
查看詳細走勢圖
350.500USD
+4.500+1.30%
交易中 美東報價延遲15分鐘
67.98B總市值
43.71本益比TTM

Cencora Inc

350.500
+4.500+1.30%
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

+1.30%

5天

+3.19%

1月

-3.16%

6月

+18.60%

今年開始到現在

+56.00%

1年

+50.92%

查看詳細走勢圖

TradingKey Cencora Inc股票評分

單位: USD 更新時間: 2025-12-12

操作建議

Cencora Inc當前公司基本面數據相對穩定,增長潛力很大。當前估值合理,在醫療設備與耗材行業排名30/208位。機構持股佔比非常高,近一個月多位分析師給出公司評級為買入。最高目標價384.45。中期看,股價處於上升通道。近一個月,市場表現一般,但公司基本面和技術面得分較高。目前股價在壓力位和支撐位之間,可以做區間波段操作。

Cencora Inc評分

相關信息

行業排名
30 / 208
全市場排名
98 / 4592
所屬行業
醫療設備與耗材

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

分析師目標

基於 18 分析師
買入
評級
384.451
目標均價
+13.80%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

Cencora Inc亮點

亮點風險
Cencora, Inc. is a global pharmaceutical sourcing and distribution services company. The Company helps both healthcare providers and pharmaceutical and biotech manufacturers improve patient access to products and enhance patient care. The Company operates through two segments: U.S. Healthcare Solutions and International Healthcare Solutions. The U.S. Healthcare Solutions segment distributes a comprehensive offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a variety of healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, long-term care and alternate site pharmacies, and other customers. The International Healthcare Solutions segment consists of businesses that focus on international pharmaceutical wholesale and related service operations and global commercialization services.
行業龍頭
公司營業收入處於行業前列,最新年度總收入321.33B美元
業績高增長
公司營業收入穩步增長,連續3年增長22.56%
高分紅
公司屬於高分紅公司,最新股息支付率28.12%
穩定分紅
公司5年內持續分紅,最新股息支付率28.12%
估值高估
公司最新PE估值43.15,處於3年歷史高位
機構加倉
最新機構持股185.17M股,環比增加0.02%
Mairs and Power 公司持倉
明星投資者Mairs and Power 公司持倉,最新持倉1.60K股

Cencora Inc新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

Cencora Inc簡介

Cencora, Inc. is a global pharmaceutical sourcing and distribution services company. The Company helps both healthcare providers and pharmaceutical and biotech manufacturers improve patient access to products and enhance patient care. The Company operates through two segments: U.S. Healthcare Solutions and International Healthcare Solutions. The U.S. Healthcare Solutions segment distributes a comprehensive offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a variety of healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, long-term care and alternate site pharmacies, and other customers. The International Healthcare Solutions segment consists of businesses that focus on international pharmaceutical wholesale and related service operations and global commercialization services.
公司代碼COR
公司Cencora Inc
CEOMauch (Robert P)
網址https://www.cencora.com/

常見問題

Cencora Inc(COR)的當前股價是多少?

Cencora Inc(COR)的當前股價是 350.500。

Cencora Inc 的股票代碼是什麼?

Cencora Inc的股票代碼是COR。

Cencora Inc股票的52週最高點是多少?

Cencora Inc股票的52週最高點是377.540。

Cencora Inc股票的52週最低點是多少?

Cencora Inc股票的52週最低點是223.920。

Cencora Inc的市值是多少?

Cencora Inc的市值是67.98B。

Cencora Inc的淨利潤是多少?

Cencora Inc的淨利潤為1.55B。

現在Cencora Inc(COR)的股票是買入、持有還是賣出?

根據分析師評級,Cencora Inc(COR)的總體評級為買入,目標價格為384.451。

Cencora Inc(COR)股票的每股收益(EPS TTM)是多少

Cencora Inc(COR)股票的每股收益(EPS TTM)是8.019。
KeyAI